1 year return (CAGR)
-64.52%
CytoMed Therapeutics Limited Ordinary Shares Exchange (NASDAQ, USD)
GDTC
0.81
-0.05 (-5.48%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-38.25%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
9.53M
Price/Sales
28.33
Ent value
8.56M
Price/Book
1.39
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-4.50%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.80 |
| Daily high | 0.85 |
| Daily low | 0.80 |
| Daily Volume | 20K |
| All-time high | 5.64 |
| 1y analyst estimate | 5.00 |
| Beta | 0.05 |
| EPS (TTM) | -0.26 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 May 2026 |
Downside potential
Loading...
Downside potential data
| GDTC | S&P500 | |
| Current price drop from All-time high | -85.72% | -2.63% |
| Highest price drop | -87.18% | -56.47% |
| Date of highest drop | 7 May 2026 | 9 Mar 2009 |
| Avg drop from high | -58.53% | -10.68% |
| Avg time to new high | 215 days | 12 days |
| Max time to new high | 799 days | 1805 days |
News
